Am J Kidney Dis 2006; 48: 183 191. 436. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: e21 e181. 437. Divers J, Freedman BI. Susceptibility genes in common complex kidney disease. Curr Opin Nephrol Hypertens 2010; 19: 79 84. references 438. Freedman BI, Sedor JR. Hypertension-associated kidney disease: perhaps no more. J Am Soc Nephrol 2008; 19: 2047 2051. 439. Flack JM, Sica DA, Bakris G et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension 2010; 56: 780 800. 440. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841 845. 441. Becker GJ, Wheeler DC. Blood pressure control in CKD patients: why do we fail to implement the guidelines? Am J Kidney Dis 2010; 55: 415 418. 442. Schmitt KE, Edie CF, Laflam P et al. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease. Am J Nephrol 2010; 32: 541 548. 443. Keenan K, Hayen A, Neal BC et al. Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. BMJ 2009; 338: b1492. 444. Owens DK, Lohr KN, Atkins D et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol 2010; 63: 513 523. 445. Guyatt GH, Oxman AD, Kunz R et al. Going from evidence to recommendations. BMJ 2008; 336: 1049 1051. 446. The AGREE Collaboration. 